Tonix Pharmaceuticals Holding Corp. - 10-Q Filing
Tonix Pharmaceuticals reports Q3 2026 financial results with segment performance across Tonmya, Zembrace Symtouch, and Tosymra.
Tickers: $TNXP
Read the full article at SEC EDGAR
Part of the story Tonix Pharmaceuticals Holding Corp. - 10-Q Filing (3 articles)